Yubo International Biotech Limited
YBGJ
$0.01
$0.01120.41%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 12.40K | 12.40K | 12.40K | 0.00 | 0.00 |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 12.40K | 12.40K | 12.40K | 0.00 | 0.00 |
| Cost of Revenue | 4.20K | 4.20K | 4.20K | -4.30K | 84.00K |
| Gross Profit | 8.20K | 8.20K | 8.20K | 4.30K | -84.00K |
| SG&A Expenses | 807.90K | 847.40K | 1.01M | 1.14M | 1.29M |
| Depreciation & Amortization | 118.10K | 162.20K | 177.70K | 175.70K | 181.70K |
| Other Operating Expenses | 206.00K | 133.20K | 135.30K | 70.60K | 131.20K |
| Total Operating Expenses | 1.14M | 1.15M | 1.32M | 1.38M | 1.69M |
| Operating Income | -1.12M | -1.13M | -1.31M | -1.38M | -1.69M |
| Income Before Tax | -1.16M | -1.14M | -1.31M | -1.38M | -1.69M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.16 | -1.14 | -1.31 | -1.38 | -1.69 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 100.80K | 99.40K | 108.70K | 147.70K | 154.50K |
| Net Income | -1.06M | -1.04M | -1.20M | -1.23M | -1.54M |
| EBIT | -1.12M | -1.13M | -1.31M | -1.38M | -1.69M |
| EBITDA | -1.01M | -972.30K | -1.13M | -1.20M | -1.51M |
| EPS Basic | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 659.47M | 608.87M | 558.27M | 507.33M | 479.28M |
| Average Diluted Shares Outstanding | 659.47M | 608.87M | 558.27M | 507.33M | 479.28M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |